Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MGX Metagenomi Inc.
- Stocks
- Healthcare
- NASDAQ: MGX
Price (delayed)
$1.46
Market cap
$54.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.11
Enterprise value
$64.57M
We are a precision genetic medicines company committed to developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set
Highlights
Metagenomi's EPS has soared by 87% YoY and by 11% from the previous quarter
The debt has declined by 8% year-on-year and by 2.9% since the previous quarter
MGX's quick ratio is up by 23% year-on-year but it is down by 15% since the previous quarter
The equity has declined by 23% year-on-year and by 9% since the previous quarter
The revenue has declined by 13% since the previous quarter and by 4.2% year-on-year
Key stats
What are the main financial stats of MGX
Market
Valuations
Earnings
Shares outstanding
37.38M
Market cap
$54.58M
Enterprise value
$64.57M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.26
Price to sales (P/S)
1.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.43
Revenue
$45.26M
Gross profit
$45.26M
Operating income
-$87.69M
Net income
-$77.95M
EBIT
-$83.36M
EBITDA
-$73.08M
Free cash flow
-$104.55M
Per share
Balance sheet
Liquidity
EPS
-$2.11
EPS diluted
-$2.11
Free cash flow per share
-$2.82
Book value per share
$5.69
Revenue per share
$1.22
TBVPS
$8.05
Total assets
$297.87M
Total liabilities
$85.21M
Debt
$44.44M
Equity
$212.66M
Working capital
$193.3M
Debt to equity
0.21
Current ratio
5.85
Quick ratio
5.82
Net debt/EBITDA
-0.14
Margins
Efficiency
Dividend
EBITDA margin
-161.5%
Gross margin
100%
Net margin
-172.2%
Operating margin
-193.7%
Return on assets
-22.8%
Return on equity
-32.1%
Return on invested capital
-27.5%
Return on capital employed
-32.3%
Return on sales
-184.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MGX stock price
How has the Metagenomi stock price performed over time
Intraday
-8.18%
1 week
0.69%
1 month
-12.05%
1 year
-61.27%
YTD
-59.56%
QTD
7.35%
Financial performance
How have Metagenomi's revenue and profit performed over time
Revenue
$45.26M
Gross profit
$45.26M
Operating income
-$87.69M
Net income
-$77.95M
Gross margin
100%
Net margin
-172.2%
The net margin has declined by 15% since the previous quarter and by 5% year-on-year
Metagenomi's operating margin has decreased by 14% QoQ and by 2.2% YoY
The revenue has declined by 13% since the previous quarter and by 4.2% year-on-year
The company's gross profit fell by 13% QoQ and by 4.2% YoY
Price vs fundamentals
How does MGX's price correlate with its fundamentals
Growth
What is Metagenomi's growth rate over time
Valuation
What is Metagenomi stock price valuation
P/E
N/A
P/B
0.26
P/S
1.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.43
Metagenomi's EPS has soared by 87% YoY and by 11% from the previous quarter
The P/B is 35% lower than the last 4 quarters average of 0.4
The equity has declined by 23% year-on-year and by 9% since the previous quarter
MGX's price to sales (P/S) is 37% lower than its last 4 quarters average of 1.9
The revenue has declined by 13% since the previous quarter and by 4.2% year-on-year
Efficiency
How efficient is Metagenomi business performance
MGX's ROA is down by 23% YoY and by 9% QoQ
Metagenomi's ROS has decreased by 22% YoY and by 15% from the previous quarter
Metagenomi's ROE has decreased by 15% YoY and by 7% from the previous quarter
The ROIC has contracted by 10% YoY
Dividends
What is MGX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MGX.
Financial health
How did Metagenomi financials performed over time
Metagenomi's total liabilities has decreased by 39% YoY and by 5% QoQ
The total assets has contracted by 28% YoY and by 8% from the previous quarter
The debt is 79% smaller than the equity
The company's debt to equity rose by 24% YoY and by 11% QoQ
The equity has declined by 23% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.